Federated Hermes’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,830
Closed -$9.59K 2159
2024
Q1
$9.59K Buy
1,830
+642
+54% +$3.36K ﹤0.01% 1779
2023
Q4
$6.21K Buy
+1,188
New +$6.21K ﹤0.01% 1833
2023
Q3
Sell
-35,240
Closed -$685K 2227
2023
Q2
$685K Sell
35,240
-31,839
-47% -$619K ﹤0.01% 1263
2023
Q1
$1.9M Sell
67,079
-3,032
-4% -$86K ﹤0.01% 974
2022
Q4
$2.05M Sell
70,111
-31,523
-31% -$921K 0.01% 901
2022
Q3
$2.69M Sell
101,634
-29,706
-23% -$785K 0.01% 830
2022
Q2
$5.84M Sell
131,340
-73
-0.1% -$3.24K 0.02% 657
2022
Q1
$6.5M Buy
131,413
+2,526
+2% +$125K 0.01% 717
2021
Q4
$6.56M Buy
128,887
+185
+0.1% +$9.42K 0.01% 749
2021
Q3
$7.18M Buy
128,702
+6,112
+5% +$341K 0.01% 736
2021
Q2
$5.25M Sell
122,590
-4,259
-3% -$182K 0.01% 821
2021
Q1
$5.3M Buy
126,849
+37,052
+41% +$1.55M 0.01% 837
2020
Q4
$4.18M Buy
89,797
+34,426
+62% +$1.6M 0.01% 854
2020
Q3
$2.35M Buy
+55,371
New +$2.35M 0.01% 929
2020
Q1
Sell
-7,932
Closed -$477K 2377
2019
Q4
$477K Sell
7,932
-29,118
-79% -$1.75M ﹤0.01% 1460
2019
Q3
$2.1M Sell
37,050
-61,305
-62% -$3.47M 0.01% 1017
2019
Q2
$5.48M Sell
98,355
-43,536
-31% -$2.42M 0.01% 755
2019
Q1
$7.16M Buy
141,891
+108,649
+327% +$5.49M 0.02% 677
2018
Q4
$1.34M Buy
+33,242
New +$1.34M ﹤0.01% 1188
2018
Q2
Sell
-8,723
Closed -$460K 2285
2018
Q1
$460K Buy
+8,723
New +$460K ﹤0.01% 1407
2016
Q1
Sell
-4,651
Closed -$412K 2185
2015
Q4
$412K Sell
4,651
-3,405
-42% -$302K ﹤0.01% 1339
2015
Q3
$596K Buy
8,056
+8,042
+57,443% +$595K ﹤0.01% 1232
2015
Q2
$1K Buy
+14
New +$1K ﹤0.01% 1916